Pharmaceutical / Drug Definition :
Binds to and blocks aldosterone receptors, disrupting normal sodium and water reabsorption and causing sodium and water excretion to increase. These actions reduce blood volume and blood pressure.
In the United States, Eplerenone is regulated by the U.S. Food and Drug Administration (FDA). FDA has specific requirements regarding the registration and listing of Eplerenone.
Registrar Corp assists Eplerenone companies with:
FDA Label Requirements and Exceptions
FDA Import Information
Eplerenone (Eplerenone Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Eplerenone (Eplerenone Suppliers)
- Processors Eplerenone
- Repackers Eplerenone
- Relabelers Eplerenone
- Exporters Eplerenone
- Importers Eplerenone
For more information about Eplerenone, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.